Ranibizumab for Myopic Neovascularization

Clinical trial NCT01246089 · UNKNOWN

Trial details

NCT number: NCT01246089
Sponsor: Instituto de Olhos de Goiania
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Myopic Choroidal Neovascularization

Start date: 2009-07-01
Primary completion: 2014-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.